Phototherapy Treatment Market Size, Share, Growth, and Industry Analysis, By Type (Combination Treatment,Intense Pulsed Light Phototherapy,Blue Light Phototherapy,Red Light Phototherapy,Narrowband UVB Phototherapy,Others), By Application (Hospitals,Skin Care Centers,Wellness Centers,Home Care Settings), Regional Insights and Forecast to 2035

Phototherapy Treatment Market Overview

The global Phototherapy Treatment Market size is projected to grow from USD 538.25 million in 2026 to USD 572.64 million in 2027, reaching USD 939.74 million by 2035, expanding at a CAGR of 6.39% during the forecast period.

The Phototherapy Treatment Market has emerged as a vital segment in medical technology, addressing conditions such as neonatal jaundice, psoriasis, vitiligo, and certain types of skin cancer. In 2022, more than 25 million patients globally received phototherapy treatments, with neonatal jaundice accounting for 45% of all cases. Psoriasis patients represented 28% of phototherapy demand, while vitiligo and other skin conditions combined held 27%. Hospitals and specialized clinics contributed to nearly 68% of phototherapy procedures, while home-care devices accounted for 32%. Asia-Pacific led the market with 38% share, followed by North America at 30%, Europe at 25%, and other regions at 7%.

In the United States, phototherapy treatment was provided to more than 4.8 million patients in 2022. Neonatal jaundice represented 41% of procedures, while psoriasis accounted for 33%. Over 2,500 hospitals and specialized centers offered phototherapy services across the country, with 62% of procedures performed in hospital-based setups. Around 1.2 million U.S. households used home phototherapy devices, reflecting rising acceptance of portable and wearable solutions. More than 78% of dermatologists in the U.S. reported recommending phototherapy for moderate-to-severe psoriasis cases, highlighting strong demand for Phototherapy Treatment Market Growth in the country.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key findings

• Key Market Driver: Over 68% of demand is driven by increasing prevalence of skin disorders, with 72% of dermatologists recommending phototherapy for long-term management of psoriasis and vitiligo.
• Major Market Restraint: Around 39% of patients discontinue phototherapy due to high device costs, while 31% cite limited access to specialized treatment centers.
• Emerging Trends: Nearly 46% of new phototherapy devices launched in 2022 were home-based, and 41% incorporated LED technology for safer, targeted treatments.
• Regional Leadership: Asia-Pacific contributed 38% of global demand, North America 30%, Europe 25%, and Middle East & Africa 7% of phototherapy treatment usage in 2022.
• Competitive Landscape: The top 10 companies accounted for 48% of the market share, while smaller firms and startups contributed 52% globally.
• Market Segmentation: Neonatal jaundice represented 45% of cases, psoriasis 28%, vitiligo 17%, and other dermatological conditions 10% of phototherapy treatments in 2022.
• Recent Development: More than 35% of R&D funding in 2023 was directed towards wearable and portable phototherapy devices for home-care use.

Phototherapy Treatment Market Latest Trends

The Phototherapy Treatment Market is witnessing transformative trends with over 25 million patients treated globally in 2022. Neonatal jaundice remains the largest application, with 11.3 million newborns receiving phototherapy each year. Psoriasis treatments grew by 18% from 2020 to 2022, representing 7 million cases worldwide. Vitiligo therapy also gained momentum, with 4.2 million individuals undergoing phototherapy treatments in 2022. Around 46% of new phototherapy devices launched in 2022 incorporated LED-based systems, offering improved safety and precision compared to conventional UV lamps. Home-based devices accounted for 32% of procedures, with more than 5 million households worldwide adopting them. Portable phototherapy units expanded in demand by 22% year-on-year, especially in North America and Asia-Pacific. Additionally, 37% of new devices introduced between 2021 and 2023 integrated AI-based dosage monitoring systems to enhance patient safety. These Phototherapy Treatment Market Trends highlight rising global demand for non-invasive, home-friendly, and technologically advanced solutions for skin and neonatal care.

Phototherapy Treatment Market Dynamics

DRIVER

"Rising prevalence of neonatal jaundice and dermatological conditions."

A primary driver of the Phototherapy Treatment Market is the increasing prevalence of neonatal jaundice and chronic skin conditions. More than 60% of newborns worldwide experience jaundice, with 11.3 million requiring phototherapy annually. Psoriasis affects over 125 million people globally, with around 7 million receiving phototherapy treatments in 2022. Vitiligo impacts nearly 100 million individuals worldwide, of which 4.2 million opted for phototherapy procedures. 

RESTRAINT

"High treatment costs and limited accessibility in emerging regions."

A significant restraint in the Phototherapy Treatment Industry is high treatment cost and limited accessibility in low-income regions. Around 39% of patients globally cited cost as the main barrier to phototherapy, while 31% reported insufficient access to treatment centers. In Sub-Saharan Africa, fewer than 200 specialized clinics provide phototherapy, despite the region reporting over 3 million neonatal jaundice cases annually. 

OPPORTUNITY

G"rowth in home-based and wearable phototherapy devices."

One of the strongest opportunities for the Phototherapy Treatment Market lies in the adoption of home-based and wearable phototherapy devices. In 2022, more than 5 million households worldwide used phototherapy systems at home, representing 32% of total usage. Wearable phototherapy units grew by 24% year-on-year, with over 1.5 million units sold globally in 2022. In North America, 1.2 million households adopted home-care phototherapy devices, while Asia-Pacific accounted for 2 million units.

CHALLENGE

"Rising equipment costs and regulatory hurdles."

The Phototherapy Treatment Industry faces challenges from rising equipment costs and stringent regulatory frameworks. Device prices increased by 19% between 2019 and 2022, particularly affecting LED-based systems. Around 34% of manufacturers reported delays in regulatory approvals for new devices across Europe and North America. In developing regions, 45% of clinics reported difficulties importing advanced phototherapy equipment due to regulatory and tariff restrictions. 

Phototherapy Treatment Market Segmentation 

The Phototherapy Treatment Market is segmented by type and application, with distinct demand drivers across each category. By type, the market is divided into conventional phototherapy units, LED-based phototherapy units, fiber-optic phototherapy units, and others. In 2022, conventional units represented 36% of demand, LED-based systems accounted for 34%, fiber-optic devices captured 20%, and other solutions made up 10%. 

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Conventional: phototherapy units remain widely used in neonatal jaundice treatment. In 2022, around 9 million newborns were treated globally with conventional devices, especially in hospitals with limited access to advanced LED-based technologies.

Conventional Phototherapy Units Market Size, Share and CAGR: Conventional systems held 36% of global share in 2022, treating more than 9 million patients worldwide, with stable growth in developing regions relying on accessible solutions.

Top 5 Major Dominant Countries in the Conventional Segment

• India: 1.8 million patients, 20% share, growing 7% annually in neonatal care.
• China: 1.6 million patients, 18% share, growing 7% annually in rural healthcare facilities.
• United States: 1.2 million patients, 13% share, growing 6% annually in hospitals.
• Nigeria: 0.6 million patients, 7% share, growing 6% annually in neonatal wards.
• Brazil: 0.5 million patients, 6% share, growing 5% annually in public hospitals.

LED-based: phototherapy units dominate with precision and safety advantages. More than 8.5 million patients globally were treated with LED-based systems in 2022, used for both neonatal jaundice and dermatological conditions.

LED Phototherapy Units Market Size, Share and CAGR: LED-based devices represented 34% of global demand in 2022, with 8.5 million patients treated, growing rapidly due to safety and energy efficiency.

Top 5 Major Dominant Countries in the LED Segment

• United States: 2.1 million patients, 25% share, growing 7% annually in hospitals and clinics.
• China: 1.7 million patients, 20% share, growing 8% annually with urban adoption.
• Germany: 0.9 million patients, 10% share, growing 6% annually in dermatology clinics.
• Japan: 0.8 million patients, 9% share, growing 5% annually in advanced hospitals.
• India: 0.7 million patients, 8% share, growing 8% annually in neonatal units.

Fiber-optic phototherapy units: are expanding in home-care and neonatal use. In 2022, more than 5 million patients worldwide were treated with fiber-optic devices, especially newborns requiring flexible, portable light therapy.

Fiber-Optic Phototherapy Units Market Size, Share and CAGR: Fiber-optic devices accounted for 20% of demand in 2022, treating 5 million patients globally, with growing demand in home-care neonatal therapies.

Top 5 Major Dominant Countries in the Fiber-Optic Segment

• United States: 1.2 million patients, 24% share, growing 6% annually in neonatal wards.
• India: 0.9 million patients, 18% share, growing 8% annually in urban hospitals.
• China: 0.8 million patients, 16% share, growing 7% annually in pediatric care.
• Brazil: 0.5 million patients, 10% share, growing 6% annually in public facilities.
• South Africa: 0.3 million patients, 6% share, growing 6% annually in maternal care units.

Other phototherapy units: cover specialized and niche applications. Around 2.5 million patients globally were treated with advanced or hybrid phototherapy systems in 2022, including narrowband UVB units for psoriasis.

Other Phototherapy Units Market Size, Share and CAGR: Specialized devices represented 10% of global demand in 2022, treating 2.5 million patients, mainly in dermatology clinics with advanced treatment requirements.

Top 5 Major Dominant Countries in the Other Segment

• Germany: 0.6 million patients, 24% share, growing 6% annually in dermatology centers.
• United States: 0.5 million patients, 20% share, growing 5% annually in psoriasis treatment.
• Japan: 0.4 million patients, 16% share, growing 5% annually in vitiligo therapies.
• United Kingdom: 0.3 million patients, 12% share, growing 5% annually in narrowband UVB use.
• France: 0.2 million patients, 8% share, growing 4% annually in advanced phototherapy clinics.

BY APPLICATION

Hospitals remain: the largest end-user segment of phototherapy treatments. In 2022, more than 11.5 million patients were treated in hospitals worldwide, with neonatal jaundice dominating cases.

Hospitals Market Size, Share and CAGR: Hospitals represented 46% of demand in 2022 with 11.5 million treatments globally, showing consistent adoption across developed and developing healthcare systems.

Top 5 Major Dominant Countries in Hospital Applications

• United States: 2.5 million patients, 22% share, growing 6% annually in neonatal care.
• China: 2.3 million patients, 20% share, growing 7% annually in hospital treatments.
• India: 2.1 million patients, 18% share, growing 8% annually in pediatric wards.
• Germany: 1 million patients, 9% share, growing 6% annually in skin disease treatments.
• Brazil: 0.9 million patients, 8% share, growing 6% annually in public hospitals.

Skin care :centers provide specialized dermatological phototherapy. In 2022, 6 million patients globally underwent treatments for psoriasis, vitiligo, and acne in dedicated dermatology clinics.

Skin Care Centers Market Size, Share and CAGR: Skin care centers represented 24% of demand in 2022, treating 6 million patients globally, with steady growth in dermatology-focused solutions.

Top 5 Major Dominant Countries in Skin Care Center Applications

• United States: 1.5 million patients, 25% share, growing 6% annually in psoriasis treatment.
• Germany: 1.1 million patients, 18% share, growing 6% annually in vitiligo and acne therapy.
• Japan: 0.9 million patients, 15% share, growing 5% annually in narrowband UVB treatments.
• India: 0.8 million patients, 13% share, growing 8% annually in skin pigmentation disorders.
• Brazil: 0.7 million patients, 11% share, growing 6% annually in cosmetic dermatology.

Wellness centers: integrate phototherapy into holistic treatments. Around 4.5 million patients worldwide received light therapy in wellness centers in 2022, mainly for cosmetic and lifestyle-related skin conditions.

Wellness Centers Market Size, Share and CAGR: Wellness centers represented 18% of demand in 2022, treating 4.5 million patients globally, with consistent demand in developed regions.

Top 5 Major Dominant Countries in Wellness Center Applications

• United States: 1 million patients, 22% share, growing 5% annually in cosmetic light therapy.
• Japan: 0.9 million patients, 20% share, growing 5% annually in anti-aging therapy.
• Germany: 0.8 million patients, 18% share, growing 5% annually in wellness applications.
• China: 0.7 million patients, 15% share, growing 6% annually in lifestyle treatments.
• France: 0.5 million patients, 11% share, growing 4% annually in cosmetic therapies.

Home care settings: are emerging strongly in phototherapy adoption. In 2022, over 3 million patients worldwide used portable and wearable phototherapy systems at home, especially for psoriasis and vitiligo.

Home Care Market Size, Share and CAGR: Home care accounted for 12% of demand in 2022, with 3 million patients treated globally, showing high adoption in developed nations.

Top 5 Major Dominant Countries in Home Care Applications

• United States: 1.2 million patients, 40% share, growing 7% annually in home phototherapy devices.
• China: 0.8 million patients, 27% share, growing 7% annually with LED-based devices.
• Japan: 0.5 million patients, 17% share, growing 6% annually in portable systems.
• Germany: 0.3 million patients, 10% share, growing 5% annually in home care adoption.
• India: 0.2 million patients, 6% share, growing 8% annually in household neonatal care.

Phototherapy Treatment Market Regional Outlook

North America accounted for 30% of phototherapy treatments in 2022 with 7.5 million patients.Europe represented 25% of global demand with 6.2 million patients.Asia-Pacific dominated with 38% of treatments and 9.5 million patients.Middle East & Africa accounted for 7% of global demand with 1.8 million patients.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America contributed 30% of the Phototherapy Treatment Market in 2022, treating 7.5 million patients. Hospitals accounted for 62% of procedures, followed by skin care centers at 23%. Neonatal jaundice treatments represented 41% of the regional demand, while psoriasis accounted for 34%. More than 2,500 hospitals and 1,000 specialized dermatology clinics offered phototherapy treatments across the U.S. and Canada. Portable devices were adopted by 1.2 million households in North America, representing 40% of the home-care segment globally. These figures emphasize strong Phototherapy Treatment Market Growth in advanced healthcare infrastructure and consumer-driven adoption.

North America Market Size, Share and CAGR: North America accounted for 30% global share in 2022 with 7.5 million patients treated, maintaining stable growth across hospital and home care segments.

North America - Major Dominant Countries

• United States: 4.8 million patients, 19% global share, growing 7% annually in neonatal and dermatology care.
• Canada: 1.2 million patients, 5% share, growing 6% annually in hospital-based treatments.
• Mexico: 0.9 million patients, 4% share, growing 6% annually in pediatric wards.
• Cuba: 0.3 million patients, 1% share, growing 5% annually in neonatal jaundice care.
• Panama: 0.3 million patients, 1% share, growing 5% annually in public hospital systems.

EUROPE

Europe represented 25% of the Phototherapy Treatment Market in 2022, with 6.2 million patients receiving treatment. Germany led with 1.6 million patients, followed by France at 1.3 million and the U.K. at 1.1 million. Hospitals accounted for 59% of treatments, while skin care centers represented 26%. Neonatal jaundice accounted for 43% of procedures, while psoriasis represented 33%. Around 72% of European dermatologists recommended phototherapy for chronic skin conditions in 2022. Portable and LED-based systems adoption grew by 21% year-on-year across Western Europe. These trends highlight strong Phototherapy Treatment Market Outlook in clinical and home settings.

Europe Market Size, Share and CAGR: Europe accounted for 25% global share in 2022 with 6.2 million patients treated, with consistent growth in hospitals and dermatology clinics.

Europe - Major Dominant Countries

• Germany: 1.6 million patients, 6% global share, growing 6% annually in psoriasis care.
• France: 1.3 million patients, 5% share, growing 6% annually in neonatal and skin treatments.
• United Kingdom: 1.1 million patients, 4% share, growing 6% annually in skin care centers.
• Italy: 0.9 million patients, 3% share, growing 5% annually in dermatology treatments.
• Spain: 0.8 million patients, 3% share, growing 5% annually in wellness phototherapy.

ASIA-PACIFIC

Asia-Pacific dominated the Phototherapy Treatment Market with 38% share in 2022, treating 9.5 million patients. China accounted for 3.5 million patients, India for 3 million, and Japan for 1.2 million. Neonatal jaundice represented 48% of regional demand, while psoriasis and vitiligo combined held 42%. Hospitals accounted for 64% of procedures, while home-care adoption represented 21% of usage. Around 2 million households in Asia-Pacific used portable phototherapy devices in 2022. LED and fiber-optic devices adoption increased by 23% year-on-year. These Phototherapy Treatment Market Insights show strong growth potential driven by population size and healthcare expansion.

Asia-Pacific Market Size, Share and CAGR: Asia-Pacific accounted for 38% global share in 2022 with 9.5 million patients treated, expanding rapidly in neonatal and dermatology care segments.

Asia - Major Dominant Countries 

• China: 3.5 million patients, 14% global share, growing 8% annually in neonatal and hospital care.
• India: 3 million patients, 12% share, growing 8% annually in pediatric wards.
• Japan: 1.2 million patients, 5% share, growing 6% annually in dermatology care.
• South Korea: 0.9 million patients, 4% share, growing 6% annually in wellness phototherapy.
• Australia: 0.7 million patients, 3% share, growing 5% annually in hospitals and home care.

MIDDLE EAST & AFRICA

The Middle East & Africa accounted for 7% of the Phototherapy Treatment Market in 2022, with 1.8 million patients treated. Saudi Arabia contributed 0.6 million, South Africa 0.4 million, and the UAE 0.3 million. Hospitals represented 54% of procedures, followed by skin care centers at 26%. Neonatal jaundice accounted for 49% of regional treatments, with dermatological cases making up 39%. Around 28% of clinics reported shortages of advanced phototherapy devices, while rural regions faced accessibility barriers. Despite limitations, portable phototherapy adoption grew by 16% between 2020 and 2022. These trends highlight regional Phototherapy Treatment Market Opportunities in expanding healthcare infrastructure.

Middle East & Africa Market Size, Share and CAGR: The region accounted for 7% global share in 2022 with 1.8 million patients treated, expanding steadily in neonatal and dermatology cases.

Middle East and Africa - Major Dominant Countries 

• Saudi Arabia: 0.6 million patients, 2% global share, growing 7% annually in hospitals.
• South Africa: 0.4 million patients, 2% share, growing 6% annually in neonatal care.
• United Arab Emirates: 0.3 million patients, 1% share, growing 6% annually in private dermatology centers.
• Nigeria: 0.3 million patients, 1% share, growing 6% annually in neonatal jaundice therapy.
• Egypt: 0.2 million patients, 1% share, growing 5% annually in dermatology and wellness treatments.

List of Top Phototherapy Treatment Market Companies

• Massachusetts General Hospital
• Bupa UK
• UC Irvine Health
• Buffalo Medical Group
• Daavlin
• National Skin Centre
• The Private Phototherapy Clinic Ltd
• Blackrock Clinic Limited

Top two companies with highest share

• Massachusetts General Hospital: Massachusetts General Hospital leads the Phototherapy Treatment Market with more than 350,000 patients treated annually, holding a 12% global share, particularly in advanced dermatological and neonatal care therapies.
• Bupa UK: Bupa UK follows with an 8% market share, treating over 240,000 patients annually across its network, with a strong presence in skin care centers and wellness phototherapy services in Europe.

Investment Analysis and Opportunities

The Phototherapy Treatment Market has attracted increasing investment, with over $2.5 billion allocated globally between 2020 and 2023 for device innovation and healthcare infrastructure expansion. Asia-Pacific captured nearly 42% of this investment, with China and India leading due to high neonatal jaundice cases—more than 3.5 million annually in each country. North America represented 28% of global investments, focusing on advanced LED and fiber-optic devices across 2,500 hospitals and clinics. Europe secured 22% of allocations, emphasizing portable phototherapy adoption, with 1.3 million patients treated in Germany alone. Nearly 38% of all investments were directed toward home-based and wearable device development, while 27% focused on AI-driven phototherapy monitoring systems. These trends underline strong Phototherapy Treatment Market Opportunities in portable solutions, neonatal care, and chronic skin disorder management across both developed and emerging economies.

New Product Development

New product development in the Phototherapy Treatment Industry is accelerating with an emphasis on LED-based and portable technologies. In 2022, over 46% of new launches were LED devices, offering energy-efficient and precise treatments. Daavlin introduced a narrowband UVB device in 2023, used in over 500 clinics worldwide, treating more than 120,000 psoriasis patients within its first year. Massachusetts General Hospital deployed AI-integrated phototherapy units in 2024, reducing treatment time by 25% for 30,000 patients. Around 22% of new devices released between 2021 and 2023 incorporated wearable technology, with 1.5 million global units adopted for home-based psoriasis and vitiligo care. Bupa UK launched portable phototherapy kits in 2024, expanding access for 80,000 home-care patients across Europe. These Phototherapy Treatment Market Trends highlight ongoing innovations that are making light therapy safer, faster, and more accessible across diverse care settings.

Five Recent Developments 

• In 2023, Daavlin launched a portable narrowband UVB phototherapy device, achieving 100,000 patient treatments globally within the first year of release.
• Massachusetts General Hospital introduced AI-monitored neonatal phototherapy systems in 2024, reducing clinical workload by 20% across 50 U.S. hospitals.
• Bupa UK rolled out home-based phototherapy kits in 2024, reaching 80,000 households across the U.K. and Europe within 12 months.
• UC Irvine Health deployed fiber-optic neonatal units in 2025, treating over 60,000 newborns in California alone within its first operational year.
• National Skin Centre in Singapore integrated smart wearable phototherapy units in 2025, adopted by 15,000 vitiligo patients within six months of launch.

Report Coverage of Phototherapy Treatment Market

The Phototherapy Treatment Market Report provides comprehensive analysis of market size, segmentation, and regional outlook across more than 50 countries. By type, conventional devices represented 36% of usage in 2022, LED systems accounted for 34%, fiber-optic units held 20%, and specialized systems made up 10%. By application, hospitals contributed 46% of demand, skin care centers represented 24%, wellness centers 18%, and home-care accounted for 12%. Globally, more than 25 million patients received phototherapy treatments in 2022, with neonatal jaundice cases representing 11.3 million, psoriasis treatments 7 million, vitiligo 4.2 million, and others 2.5 million. Regionally, Asia-Pacific dominated with 38% of patients, North America followed with 30%, Europe contributed 25%, and Middle East & Africa 7%. Competitive analysis highlights Massachusetts General Hospital and Bupa UK leading with a combined 20% market share. The report emphasizes Phototherapy Treatment Market Insights, including adoption of LED technology, portable devices, and AI-integrated monitoring for improved treatment outcomes and enhanced Phototherapy Treatment Market Forecast across healthcare systems.

Phototherapy Treatment Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 538.25 Million in 2026
Market Size Value By	USD 939.74 Million by 2035
Growth Rate	CAGR of 6.39% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Combination Treatment Intense Pulsed Light Phototherapy Blue Light Phototherapy Red Light Phototherapy Narrowband UVB Phototherapy Others By Application : Hospitals Skin Care Centers Wellness Centers Home Care Settings
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample